Larvol Delta - NextGeneration-Peptide-Receptor-Radionuclide-Therapy-A-Phase-1-DoseEscalation-and-Dosimetry-Study-of-177LuDOTAEBTATE

Arzerra (ofatumumab) - Novartis, Genmab

http://www.ncbi.nlm.nih.gov/pubmed/42788399

Jian Wang; MengJiao Li; Ping Kong

Sep 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next